Epidemiological trends in the diagnosis of melanoma in a Southern European population: analysis of a large database from a tertiary referral center-Reference-Cited by-同舟云学术

Epidemiological trends in the diagnosis of melanoma in a Southern European population: analysis of a large database from a tertiary referral center

Published:2018-08 Issue:4 Volume:28 Page:348-358
ISSN:0960-8931
Container-title:Melanoma Research
language:en
Short-container-title:

Author:

Tsoutsos Dimosthenis,Papadopoulos Stefanos,Kehagias George,Mara Aristea,Kyriopoulou Eugenia,Karonidis Athanasios,Spiliopoulos Konstantinos,Mpalitsaris Efstathios,Karapiperis George,Panayotou Peter,Papaliodi Eugenia,Choreftaki Theodosia,Papaxoinis George,Benopoulou Olga,Ioannovich John,Gogas Helen

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Dermatology,Oncology

Reference26 articles.

1. Melanoma/skin cancer screening in a Mediterranean country: results of the Euromelanoma Screening Day Campaign in Greece;Stratigos;J Eur Acad Dermatol Venereol,2007

2. Cutaneous melanoma in Turkey: analysis of 1157 patients in the Melanoma Turkish Study;Abali;J BUON,2015

3. Melanoma in South-East Europe: epidemiological data from the central cancer registry and clinicopathological characteristics from the hospital-based registry in Serbia;Kandolf-Sekulović;Int J Dermatol,2012

4. Prognostic differences across sexes in melanoma patients: what has changed from the past?;Sanlorenzo;Melanoma Res,2014

5. Melanoma characteristics at diagnosis from the Spanish National Cutaneous Melanoma Registry: 15 years of experience;Ríos;Actas Dermosifiliogr,2013

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Postmarketing surveillance of nivolumab plus ipilimumab combination therapy in Japanese patients with unresectable malignant melanoma;The Journal of Dermatology;2023-06-22

2. Safety and effectiveness of nivolumab in Japanese patients with malignant melanoma: Final analysis of a post‐marketing surveillance;The Journal of Dermatology;2022-05-23

3. Five‐year survival with nivolumab in previously untreated Japanese patients with advanced or recurrent malignant melanoma;The Journal of Dermatology;2021-03-14

4. The role of vascular mimicry as a biomarker in malignant melanoma: a systematic review and meta-analysis;BMC Cancer;2019-11-21

5. Long‐term follow up of nivolumab in previously untreated Japanese patients with advanced or recurrent malignant melanoma;Cancer Science;2019-05-23